1-2 of 2
Michael Eckart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Redefining early vs late progressive disease (PD) in chronic lymphocytic leukemia: A pooled analysis of fixed-duration therapies

Free
Florian Simon, Rudy Ligtvoet, Moritz Fürstenau, Sandra Robrecht, Can Zhang, Nadine Kutsch, Julia Von Tresckow, Valentin Goede, Anna Maria Fink, Philipp Staber, Thomas Noesslinger, Christian Poulsen, Thomas Illmer, Lothar Müller, Ursula Vehling-Kaiser, Michael Eckart, Liliya Sivcheva, Javier Loscertales, Kathleen Jentsch-Ullrich, Holger Hebart, Mark-David Levin, Caspar da Cunha-Bang, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Arnon Kater, Carsten Niemann, Kirsten Fischer, Paula Cramer, Petra Langerbeins, Michael Hallek, Barbara Eichhorst, Othman Al-Sawaf
Journal: Blood
Blood (2025) 146 (Supplement 1): 2107.
https://doi.org/10.1182/blood-2025-2107
Published: 2025
Journal Articles

Bendamustine in Combination with Rituximab (BR) for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase II Trial of the German CLL Study Group (GCLLSG).

Free
Kirsten Fischer, MD, Stephan Stilgenbauer, MD, Carmen D. Schweighofer, MD, Jasmin Renschler, Raymonde Busch, Michael Kiehl, MD, Leopold Balleisen, MD, Michael Eckart, MD, Anna M. Fink, MD, Sebastian Boettcher, MD, Matthias Ritgen, MD, Michael Kneba, MD, Peter Staib, MD, Hartmut Doehner, MD, Barbara F. Eichhorst, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, the German CLL Study Group (GCLLSG)
Journal: Blood
Blood (2007) 110 (11): 3106.
https://doi.org/10.1182/blood.V110.11.3106.3106
Published: 2007